Airsonett.uk

US DISCLAIMER
The Airsonett website describes products and indications for European market customers. In the US other regulatory aspects apply. For information regarding US please go to US Site

news	Airsonett new corporate web Airsonett Deutschland GmbH win prestigious award FDA market clearance facilitates international expansion Peter Ekolind appointed Marketing and Sales Director

Company		Surgical Environment		Asthma
Board and Management Company Profile Press Releases & News Vacancies Contact Us How to Find Us		Infection Control Our Product References		What is Asthma? How to Treat Asthma Our Product Indication Clinical References Order Filters Support

Airsonett is a research based medical technology company. Its TLA technology is used as a prophylactic treatment of allergic asthma (Protexo) and infection control in operating theatres (Opragon).

Logon